Dublin, Feb. 01, 2023 (GLOBE NEWSWIRE) — The “Europe Compounding Pharmacies Market: Analysis By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), By End Users, By Type, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)” report has been added to ResearchAndMarkets.com’s offering. The report presents the analysis of the European Compounding Pharmacies Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028. The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028. The European Compounding Pharmacies Market was valued at USD 3314.80 Million in the year 2021 with Italy holding the largest market share. In terms of segments, the availability of a diverse range of compounded formulas for dermatological purposes will drive segment expansion. Patients who are allergic to commercial pharmaceuticals might benefit from dermatology customized treatments. The European Compounding Pharmacies market is a consolidated market. The major players in the market like Athenex, Baxter International, Fagron, Grifols, Capsa Healthcare, Nephron Pharmaceuticals, B. Braun, Fresenius, McKesson and Omnicell have a large geographical presence and a highly diversified product portfolio. These players focus on R&D, a large product portfolio, a wide geographical presence and an aggressive acquisition strategy. Italy is holding the largest market share and is growing at the fastest rate during the forecast period, owing to the rising prevalence of therapeutic areas as well as the widespread use of pain management in developed countries like the United Kingdom and Germany. The United Kingdom Compounding Pharmacies market has witnessed growth in recent years due to increased investments and offtake agreements among new companies to cope with new market strategies. France is a lucrative market because of the presence of several compounding pharmacies, high adoption among people, and scarcity of many drugs, which are key factors for market growth. Scope of the Report The report analyzes the Europe Compounding Pharmacies Market by Value (USD Million). The report analyzes the Europe Compounding Pharmacies by Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, and O ther Sources). The report analyzes the Europe Compounding Pharmacies Market), by End Users (Adult, Pediatric, Others, Geriatric, Veterinary). Types).The Europe Compounding Pharmacies Market has been analyzed by Country (United Kingdom, Germany, France, Italy, Spain, Russia, Turkey, Benelux, Nordic, and Rest of Europe).The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by country, by Therapeutic Area, by End Users, by Type.Also, the major opportunities, trends, drivers and challenges of the industry has been analyzed in the report.The report tracks competitive developments , strategies, and recent developments. The companies analyzed in the report include AthenexBaxter InternationalFagronGrifolsCapsa HealthcareNephron PharmaceuticalsB. Braun Fresenius McKesson Omnicell Key Metrics Report Attribute Details No. of Pages 275 Forecast Period 2022 – 2028 Estimated Market Value (USD) in 2022 $3.56 Billion Forecasted Market Value (USD) by 2028 $5.69 Billion Compound Annual Growth Rate 8.1% Regions Covered Europe Key Topics Covered: 1. Introduction 1.1 Compounding Pharmacies Market Overview 1.2 Scope of Research Executive Summary2.1 Market Snapshot2.2 Country Insights2.3 Market Ecosystem Factors3. Research Methodology3.1 Data Collection Process3.3 Market Size Calculation-Top-to-Bottom4. Market Dynamics4.1 Drivers4.2 Restraints4.3 Opportunities4.4 Analyst Recommendations4.5 Trends4.6 Impact Analysis5. COVID-19 Impact Assessment5.1 Degree of Impact of COVID-19 on Compounding Pharmacies Market6. Porter’s Five Forces analysis7. Macro Economic Indicator Outlook7.1 GDP per capita growth (USD)7.2 Breakdown of Total Healthcare Expenditure (THE) in Europe – 20217.3Current Healthcare Expenditure7.4 Pharmaceutical Spending/capita8. Europe compounding Pharmacies Market8.1 Impact Analysis of Macro Economic Factors on Compounding Pharmacies Market8.2 Snapshot8.3 Europe Compounding Pharmacies Market: Market Value Assessment8.4 Market Summary9. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Therapeutic Area9.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, Therapeutic Area: Snapshot9.2 Hormone Replacement9.3 Pain Management9.4 Dermatology9.5 Other Sources10. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By End Users10.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, End Users: Snapshot10.2 Adult10.3 Paediatric10.4 Geriatric10.5 Veterinary11. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Type11.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, By Type: Snapshot11.2 Oral11.3 Topical11.4 Ophthalmic11.5 Injectables11.6 Other Types12. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Country For more information about this report visit https://www.researchandmarkets.com/r/aptgsb About ResearchAndMarkets.comResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. European Compounding Pharmacies Market